April 20, 2024, 10:06 am


Diplomatic correspondent

Published:
2021-05-22 18:23:43 BdST

Covid-19 vaccineChina to gift additional 6 lakh doses to Bangladesh


China on Friday announced to provide Bangladesh with six lakhs more COVID-19 vaccines as gift saying in future China is willing to provide the necessary support for Bangladesh.

Earlier on May 12, China in its first batch provided 5 lakh vaccines manufactured by the Sinopharm.

Chinese State Councilor and Foreign Minister Wang Yi had a phone conversation with Bangladesh Foreign Minister AK Abdul Momen on Friday evening (May 21) at the request of the latter, and announced that China would gift the second batch of 600,000 doses of COVID-19 vaccines to Bangladesh.

“China pays close attention to the latest situation of the epidemic in Bangladesh,” said a press statement of the Chinese Embassy in Dhaka.

“At the critical time point in Bangladesh’s fight against the epidemic, China is concerned about the urgent need for vaccine of Bangladeshi friends and over comes the huge demand for domestic and foreign orders and the shortage of vaccine supply,” reads the statement.

It said Just 9 days after the arrival of the first batch of 500,000d doses of gift vaccine in Bangladesh, China once again announced the provision of the second batch of gift vaccines to Bangladesh, which fully reflects that China attaches great importance to the friendly relations between the two countries.

It is believed that the arrival of the second batch of Chinese gift vaccine will definitely help the Bangladeshi government and people build a strong line of defense against the epidemic.

In the future, China is willing to provide the necessary support for Bangladesh and South Asian countries to fight the epidemic, deepen anti-epidemic cooperation with Bangladesh, and effectively protect the health and life safety of the people of the two countries, the statement added.

Unauthorized use or reproduction of The Finance Today content for commercial purposes is strictly prohibited.


Popular Article from COVID-19